Search

everythinglearnresearchcommunity

for

Search:↓

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

ELIP-based CRISPR delivery improves heart disease gene editing but needs more testing.

Liposomes show promise for delivering CRISPR for gene editing but face challenges like delivery efficiency and safety concerns.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

BCG site reactions after COVID-19 mRNA vaccination are mild, temporary, and likely under-reported.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

BST2 is a key marker for hair loss disease alopecia areata.

The hepatitis B vaccine did not cause hair loss in the tested mice.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

BTNL2 helps protect hair follicles from immune attacks.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

New vaccine technologies are improving global health by making vaccines more effective and long-lasting.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Promising cancer treatments were found, but the manufacturer closed.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

BCG injection helps reduce long COVID symptoms and affects hair loss differently in men and women.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.